Human immunodeficiency virus type 1 vpr gene induces phenotypic effects similar to those of the DNA alkylating agent, nitrogen mustard

被引:80
作者
Poon, B
Jowett, JBM
Stewart, SA
Armstrong, RW
Rishton, GM
Chen, ISY
机构
[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,DIV HEMATOL ONCOL,LOS ANGELES,CA 90095
[2] UNIV CALIF LOS ANGELES,SCH MED,DEPT MICROBIOL & IMMUNOL,LOS ANGELES,CA 90095
[3] UNIV CALIF LOS ANGELES,DEPT CHEM & BIOCHEM,LOS ANGELES,CA 90095
[4] AMGEN INC,SMALL MOL DRUG DISCOVERY,THOUSAND OAKS,CA 91320
关键词
D O I
10.1128/JVI.71.5.3961-3971.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The product of the human immunodeficiency virus type 1 (HIV-1) vpr gene induces cell cycle arrest in the G(2) phase of the cell cycle and is characterized by an accumulation of the hyperphosphorylated form of cdc2 kinase. This phenotype is similar to the effect of DNA-damaging agents, which can also cause cells to arrest at G(2). We previously reported that Vpr mimicked some of the effects of a DNA alkylating agent known as nitrogen mustard (HN2). Here we extend these earlier observations by further comparing the activation state of cdc2 kinase, the kinetics of G(2) arrest, and the ability to reverse the arrest with chemical compounds known as methylxanthines, Infection of cells synchronized in the G(1) phase of the cell cycle with a pseudotyped HIV-1 resulted in arrest at G(2) within 12 h postinfection, before the first mitosis, Similar to that induced by HN2, Vpr-induced arrest led to a decrease in cdc2 kinase activity. Vpr-mediated G(2) arrest was alleviated by methylxanthines at concentrations similar to those needed to reverse the G(2) arrest induced by HN2, and cells proceeded apparently normally through at least one complete cell cycle, These results are consistent with the hypothesis that Vpr induces G(2) arrest through pathways that are similar to those utilized by DNA-damaging agents.
引用
收藏
页码:3961 / 3971
页数:11
相关论文
共 48 条
[1]   PHARMACOLOGY OF PENTOXIFYLLINE - A HEMORHEOLOGIC AGENT FOR THE TREATMENT OF INTERMITTENT CLAUDICATION [J].
AVIADO, DM ;
DETTELBACH, HR .
ANGIOLOGY, 1984, 35 (07) :407-417
[2]   DISTINCT EFFECTS IN PRIMARY MACROPHAGES AND LYMPHOCYTES OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACCESSORY GENES VPR, VPU, AND NEF - MUTATIONAL ANALYSIS OF A PRIMARY HIV-1 ISOLATE [J].
BALLIET, JW ;
KOLSON, DL ;
EIGER, G ;
KIM, FM ;
MCGANN, KA ;
SRINIVASAN, A ;
COLLMAN, R .
VIROLOGY, 1994, 200 (02) :623-631
[3]   Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G(2) accumulation by a mechanism which differs from DNA damage checkpoint control [J].
Bartz, SR ;
Rogel, ME ;
Emerman, M .
JOURNAL OF VIROLOGY, 1996, 70 (04) :2324-2331
[4]  
BOUBAMDAN M, 1996, J VIROL, V70, P697
[5]  
COHEN EA, 1990, J ACQ IMMUN DEF SYND, V3, P11
[6]   STRUCTURE OF PARENTAL DEOXYRIBONUCLEIC-ACID OF SYNCHRONIZED HELA-CELLS [J].
COLLINS, JM ;
BERRY, DE ;
COBBS, CS .
BIOCHEMISTRY, 1977, 16 (25) :5438-5444
[7]   VPR IS REQUIRED FOR EFFICIENT REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN MONONUCLEAR PHAGOCYTES [J].
CONNOR, RI ;
CHEN, BK ;
CHOE, S ;
LANDAU, NR .
VIROLOGY, 1995, 206 (02) :935-944
[8]  
Daly J, 1993, CAFFEINE COFFEE HLTH, P97
[9]  
DEZUBE BJ, 1993, J ACQ IMMUN DEF SYND, V6, P787
[10]   PENTOXIFYLLINE FOR THE TREATMENT OF INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].
DEZUBE, BJ .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (03) :285-287